NRG BN011

Primary Category:

Treatment Protocols

Disease Category:

Brain

Status:

New, Open

A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma

NCT#05095376